Factors contributing to tumor shrinkage after peptide receptor radionuclide therapy in patients with unresectable neuroendocrine tumors

被引：0
|
作者：
Noritoshi, K. [1 ]
Sho, H. [1 ]
Wild, D. [2 ]
Kaul, F. [2 ]
Motokazu, S. [1 ]
Naoki, O. [1 ]
Risa, F. [1 ]
Akihiro, S. [1 ]
Motohiko, T. [1 ]
Shoko, T. [1 ]
Yasushi, I [1 ]
机构：
[1] Yokohama City Univ, Yokohama, Kanagawa, Japan
[2] Univ Hosp Basel, Basel, Switzerland
来源：
JOURNAL OF NEUROENDOCRINOLOGY | 2023年 / 35卷
关键词：
lesion-based analysis; neuroendocrine tumor; peptide receptor radionuclide therapy;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H29
引用
收藏
页码：201 / 201
页数：1
相关论文
共 50 条
  • [1] Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors
    Hasegawa, Sho
    Kobayashi, Noritoshi
    Wild, Damian
    Kaul, Fesupplix
    Okubo, Naoki
    Suzuki, Akihiro
    Kurita, Yusuke
    Takano, Shoko
    Nakajima, Atsushi
    Ichikawa, Yasushi
    CANCERS, 2022, 14 (14)
  • [2] The Use of Peptide Receptor Radionuclide Therapy in Patients With Neuroendocrine Tumor Cardiac Metastases
    Yu, Irene S.
    Funk, Gayle
    Lin, Eugene
    Kennecke, Hagen F.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (01) : e23 - e26
  • [3] Peptide receptor radionuclide therapy for patients with advanced pancreatic neuroendocrine tumors
    Ramage, John
    Naraev, Boris G.
    Halfdanarson, Thorvardur R.
    SEMINARS IN ONCOLOGY, 2018, 45 (04) : 236 - 248
  • [4] Tumor Cystic Necrosis Following Peptide Receptor Radionuclide Therapy in Neuroendocrine Tumors
    Ladwa, Rahul
    Wen Hong, Hooi
    Wyld, David
    Pattison, David A.
    Burge, Matthew
    CLINICAL NUCLEAR MEDICINE, 2018, 43 (03) : 186 - 187
  • [5] Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors
    Bodei, Lisa
    Cremonesi, Marta
    Kidd, Mark
    Grana, Chiara M.
    Severi, Stefano
    Modlin, Irvin M.
    Paganelli, Giovanni
    THORACIC SURGERY CLINICS, 2014, 24 (03) : 333 - +
  • [6] Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
    Kwekkeboom, Dik J.
    Krenning, Eric P.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (01) : 179 - +
  • [7] Retrospective study of peptide receptor radionuclide therapy for Japanese patients with advanced neuroendocrine tumors
    Kobayashi, Noritoshi
    Wild, Damian
    Kaul, Felix
    Shimamura, Takeshi
    Takano, Shoko
    Takeda, Yuma
    Okubo, Naoki
    Suzuki, Akihiro
    Tokuhisa, Motohiko
    Ichikawa, Yasushi
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2021, 28 (09) : 727 - 739
  • [8] Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors
    Lo Russo, Giuseppe
    Pusceddu, Sara
    Prinzi, Natalie
    Imbimbo, Martina
    Proto, Claudia
    Signorelli, Diego
    Vitali, Milena
    Ganzinelli, Monica
    Maccauro, Marco
    Buzzoni, Roberto
    Seregni, Ettore
    de Braud, Filippo
    Garassino, Marina Chiara
    TUMOR BIOLOGY, 2016, 37 (10) : 12991 - 13003
  • [9] Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy
    van Vliet, Esther I.
    Teunissen, Jaap J. M.
    Kam, Boen L. R.
    de Jong, Marion
    Krenning, Eric P.
    Kwekkeboom, Dik J.
    NEUROENDOCRINOLOGY, 2013, 97 (01) : 74 - 85
  • [10] Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors
    Santo, Giulia
    di Santo, Gianpaolo
    Cicone, Francesco
    Virgolini, Irene
    JOURNAL OF NEUROENDOCRINOLOGY, 2025, 37 (03)
12345